Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2009 1
2010 1
2011 2
2012 1
2013 2
2015 1
2016 1
2018 9
2019 9
2020 8
2021 11
2022 7
2023 4
2024 12
2025 15
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Flow MR fingerprinting.
Flassbeck S, Schmidt S, Bachert P, Ladd ME, Schmitter S. Flassbeck S, et al. Among authors: schmidt s. Magn Reson Med. 2019 Apr;81(4):2536-2550. doi: 10.1002/mrm.27588. Epub 2018 Dec 2. Magn Reson Med. 2019. PMID: 30506796
Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database.
Gajdos L, Buetti N, Tabah A, Ruckly S, Akova M, Sjöval F, Arvaniti K, de Waele J, Bracht H, Barbier F, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP) and the OUTCOMEREA Network. Gajdos L, et al. Intensive Care Med. 2025 Mar;51(3):518-528. doi: 10.1007/s00134-025-07857-6. Epub 2025 Apr 7. Intensive Care Med. 2025. PMID: 40192823
Correction: Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database.
Gajdos L, Buetti N, Tabah A, Ruckly S, Akova M, Sjöval F, Arvaniti K, de Waele J, Bracht H, Barbier F, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP) and the OUTCOMEREA Network. Gajdos L, et al. Intensive Care Med. 2025 Oct;51(10):1968-1970. doi: 10.1007/s00134-025-08071-0. Intensive Care Med. 2025. PMID: 40828470 No abstract available.
Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trial.
Kjærsgaard L, Wiedemann J, Singer W, Takeda A, Berger AK, Flensburg MF, Hansen L, Kallunki P, Kompus K, Nighah K, Schmidt SN, Jørgensen MN, Svanholm Fogh B, Zanigni S, Luthman J; AMULET Trial Group. Kjærsgaard L, et al. Among authors: schmidt sn. Lancet Neurol. 2026 Jun;25(6):560-570. doi: 10.1016/S1474-4422(26)00100-6. Epub 2026 Apr 24. Lancet Neurol. 2026. PMID: 42044642 Clinical Trial.
4D flow imaging with 2D-selective excitation.
Wink C, Ferrazzi G, Bassenge JP, Flassbeck S, Schmidt S, Schaeffter T, Schmitter S. Wink C, et al. Among authors: schmidt s. Magn Reson Med. 2019 Sep;82(3):886-900. doi: 10.1002/mrm.27769. Epub 2019 Apr 19. Magn Reson Med. 2019. PMID: 31002417
At the cutting-edge of grape and wine biotechnology.
Borneman AR, Schmidt SA, Pretorius IS. Borneman AR, et al. Among authors: schmidt sa. Trends Genet. 2013 Apr;29(4):263-71. doi: 10.1016/j.tig.2012.10.014. Epub 2012 Dec 4. Trends Genet. 2013. PMID: 23218459 Review.
82 results